Literature DB >> 27511187

How reliable is 18FDG PET for predicting the onset of Huntington's disease?

Andrea Ciarmiello1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27511187     DOI： 10.1007/s00259-016-3483-5

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  21 in total

1.  On the uniqueness of cerebral blood flow measured by the in vivo autoradiographic strategy and positron emission tomography.

Authors:  B E Howard; M D Ginsberg; W R Hassel; A H Lockwood; P Freed
Journal:  J Cereb Blood Flow Metab       Date:  1983-12       Impact factor: 6.200

2.  The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease.

Authors:  S E Andrew; Y P Goldberg; B Kremer; H Telenius; J Theilmann; S Adam; E Starr; F Squitieri; B Lin; M A Kalchman
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

3.  Thalamic metabolism and symptom onset in preclinical Huntington's disease.

Authors:  A Feigin; C Tang; Y Ma; P Mattis; D Zgaljardic; M Guttman; J S Paulsen; V Dhawan; D Eidelberg
Journal:  Brain       Date:  2007-09-24       Impact factor: 13.501

4.  Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset.

Authors:  Nancy S Wexler; Judith Lorimer; Julie Porter; Fidela Gomez; Carol Moskowitz; Edith Shackell; Karen Marder; Graciela Penchaszadeh; Simone A Roberts; Javier Gayán; Denise Brocklebank; Stacey S Cherny; Lon R Cardon; Jacqueline Gray; Stephen R Dlouhy; Sandra Wiktorski; Marion E Hodes; P Michael Conneally; Jack B Penney; James Gusella; Jang-Ho Cha; Michael Irizarry; Diana Rosas; Steven Hersch; Zane Hollingsworth; Marcy MacDonald; Anne B Young; J Michael Andresen; David E Housman; Margot Mieja De Young; Ernesto Bonilla; Theresa Stillings; Americo Negrette; S Robert Snodgrass; Maria Dolores Martinez-Jaurrieta; Maria A Ramos-Arroyo; Jacqueline Bickham; Juan Sanchez Ramos; Frederick Marshall; Ira Shoulson; Gustavo J Rey; Andrew Feigin; Norman Arnheim; Amarilis Acevedo-Cruz; Leticia Acosta; Jose Alvir; Kenneth Fischbeck; Leslie M Thompson; Angela Young; Leon Dure; Christopher J O'Brien; Jane Paulsen; Adam Brickman; Denise Krch; Shelley Peery; Penelope Hogarth; Donald S Higgins; Bernhard Landwehrmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205

5.  Molecular analysis of juvenile Huntington disease: the major influence on (CAG)n repeat length is the sex of the affected parent.

Authors:  H Telenius; H P Kremer; J Theilmann; S E Andrew; E Almqvist; M Anvret; C Greenberg; J Greenberg; G Lucotte; F Squitieri
Journal:  Hum Mol Genet       Date:  1993-10       Impact factor: 6.150

6.  A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.

Authors:  D R Langbehn; R R Brinkman; D Falush; J S Paulsen; M R Hayden
Journal:  Clin Genet       Date:  2004-04       Impact factor: 4.438

7.  Positron emission tomographic scan investigations of Huntington's disease: cerebral metabolic correlates of cognitive function.

Authors:  S Berent; B Giordani; S Lehtinen; D Markel; J B Penney; H A Buchtel; S Starosta-Rubinstein; R Hichwa; A B Young
Journal:  Ann Neurol       Date:  1988-06       Impact factor: 10.422

8.  Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease.

Authors:  J C Mazziotta; M E Phelps; J J Pahl; S C Huang; L R Baxter; W H Riege; J M Hoffman; D E Kuhl; A B Lanto; J A Wapenski
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245

9.  PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline.

Authors:  A B Young; J B Penney; S Starosta-Rubinstein; D S Markel; S Berent; B Giordani; R Ehrenkaufer; D Jewett; R Hichwa
Journal:  Ann Neurol       Date:  1986-09       Impact factor: 10.422

10.  Positron emission tomography in the early diagnosis of Huntington's disease.

Authors:  M R Hayden; W R Martin; A J Stoessl; C Clark; S Hollenberg; M J Adam; W Ammann; R Harrop; J Rogers; T Ruth
Journal:  Neurology       Date:  1986-07       Impact factor: 9.910
View more
  1 in total

1.  Longitudinal cognitive decline in mild cognitive impairment subjects with early amyloid-β neocortical deposition.

Authors:  Andrea Ciarmiello; E Giovannini; M Riondato; G Giovacchini; V Duce; O Ferrando; M De Biasi; C Passera; E Carabelli; A Mannironi; L Mansi; A Tartaglione
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-01       Impact factor: 9.236
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.